Where does Biocrine AB rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Biocrine AB ranks #14,494 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Biocrine AB hold?

Biocrine AB holds 20 US utility patents granted between 2015 and 2023, spanning 7 technology areas.

What is Biocrine AB's Innovation Score?

Biocrine AB has an Innovation Score of 29.8 out of 100 (32nd percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Biocrine AB focus on?

Biocrine AB's top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 16 patents, ranking #1,413 of 7,163 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

Is Biocrine AB's patent grant rate increasing or decreasing?

Biocrine AB's recent grant velocity is -82% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Biocrine AB's patents?

Biocrine AB's patents average 12.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Biocrine AB patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Biocrine AB

USPTO PatentsView assignee record - 20 granted patents across 7 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Biocrine ranks #14,494 of 49,997 tracked US assignees by granted-patent volume, with 20 patents across 7 technology areas.

#14,494
of 49,997 US assignees by volume: 32nd percentile
by Innovation Score (29.8/100): 12.8
avg claims per patent: -82%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R14494 · Foreign Corporation #14,494 · 20 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 20 grants
MID-PACK #14,494/49,997
PHOTO-FINISH Bfkw
CPC-NARROW A61K · 7 areas
INNOV-THIN 29.8/100
CLAIMS-RICH 12.8 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -82% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Bfkw, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Biocrine’s 29.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.5 pts (35%) Velocity 2.2 pts (7%) Breadth 9.4 pts (32%) Claim depth 7.7 pts (26%)

Qualcomm Incorporated · highest

85
Biocrine AB · this assignee

30
3D Lighting… · lowest

7

What this shows Biocrine's Innovation Score is 29.8/100 (32nd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Biocrine?

Each dot is one of Biocrine’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Biocrine’s own 12.8 claims/patent is ABOVE the 12.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Biocrine vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Biocrine's grants concentrate

Biocrine AB is a focused PatentsView assignee: 7 CPC subclasses with 80% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2019 (5 grants) versus a trough of 1 in 2020. By volume, Biocrine sits between Bfkw, LLC and Boehringer Ingelheim Microparts GMBH.

Biocrine's three-year grant acceleration

Biocrine AB shows 2 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Bfkw

20
BGC Partners

20
Bigmouth

20
Bio-rad Innovatio…

20
Biomed Packaging…

20
Biotage AB

20
Blizzard Entertai…

20
Boehringer Ingelh…

20
Biocrine AB ◀

20

What this shows Biocrine holds 20 patents at rank #14,486, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Biocrine

By rank, the assignees closest to #14,486 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Biocrine's primary technology class.

Biocrine's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

30 32nd percentile higher than 32% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Biocrine AB patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	4	20.0%
2016	3	15.0%
2017	3	15.0%
2018	2	10.0%
2019	5	25.0%
2020	1	5.0%
2022	1	5.0%
2023	1	5.0%

Which technologies does Biocrine AB patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 16

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 16

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 15

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 11

C07K - Peptides 7

A61B - DIAGNOSIS; SURGERY; Identification 5

A01K - Animal HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; Rearing OR Breeding Animals, NOT Otherwise Provided FOR; NEW Breeds OF Animals 4

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Biocrine AB's patent record in context - here's where to go next.

Biocrine AB's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 80% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #14,494 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Biocrine AB against Bfkw, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 29.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.